Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Preclinical Studies (STTR [R42])
The summary for the Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Preclinical Studies (STTR [R42]) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Preclinical Studies (STTR [R42]): - The purpose of this Funding Opportunity Announcement (FOA) is to solicit from NICHD-supported STTR Phase II awardees, competing continuation applications that propose to continue the process of assessing and improving devices or conducting preclinical studies of drugs or devices that ultimately require: 1) clinical evaluation, 2) approval of a Federal regulatory agency, and 3) continuing refinements to durable medical equipment (DME) designs such as cost reduction, testing for safety, durability, and reliability, and meeting or establishing standards. Such products include, but are not limited to, devices, drugs, vaccines, medical implants, etc. related to the mission of the NICHD. - Awards in response to this solicitation are expected to average in the range of $150,000 to $300,000 total costs per year for up to three years. - The anticipated number of awards will depend upon the scientific/technical merit of applications received and the availability of funds. - This FOA will utilize the Phase II Small Business Technology Transfer (STTR [R42]) grant mechanism and runs in parallel with a FOA of identical scientific intent, PA-06-030, that solicits applications under the Phase II Small Business Technology Transfer Research program (STTR [R42]) grant mechanisms.
|Federal Grant Title:||Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Preclinical Studies (STTR [R42])|
|Federal Agency Name:||National Institutes of Health|
|Grant Categories:||Health Income Security and Social Services|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||PA-06-029|
|Type of Funding:||Grant|
|CFDA Descriptions:||Child Health and Human Development Extramural Research|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Multiple Receipt Dates - See Link to Full Announce|
|Posted Date:||Oct 21, 2005|
|Creation Date:||Oct 21, 2005|
|Archive Date:||Apr 14, 2006|
|Total Program Funding:|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Only United States small business concerns (SBCs) are eligible to submit STTR applications. A small business concern is one that, at the time of award for both Phase I and Phase II awards, meets all of the following criteria: - Is independently owned and operated, is not dominant in the field of operation in which it is proposing, has a place of business in the United States and operates primarily within the United States or makes a significant contribution to the US economy, and is organized for profit. - Is at least 51 percent owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States. - Has, including its affiliates, an average number of employees for the preceding 12 months not exceeding 500, and meets the other regulatory requirements found in 13 C.F.R. Part 121. Business concerns are generally considered to be affiliates of one another when either directly or indirectly, (a) one concern controls or has the power to control the other; or (b) a third-party/parties controls or has the power to control both. Control can be exercised through common ownership, common management, and contractual relationships. The term "affiliates" is defined in greater detail in 13 C.F.R. 121.103. The term "number of employees" is defined in 13 C.F.R. 121.106. A business concern may be in the form of an individual proprietorship, partnership, limited liability company, corporation, joint venture, association, trust, or cooperative. Further information may be obtained at http://sba.gov/size, or by contacting the Small Business Administration's (SBA) Government Contracting Area Office or Office of Size Standards.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
- Similar Government Grants
- • NCMRR Early Career Research Award (R03)
- • Fertility Status as a Marker for Overall Health (R21)
- • Fertility Status as a Marker for Overall Health (R01)
- • Integrative Research in Gynecologic Health (R01)
- • Moving Beyond Standard Assessments: Applying Novel Tools to Assess Human Placental Structu...
- • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...
- • Reproductive Genetics and Epigenetics
- • Developmental Mechanisms of Human Structural Birth Defects
- More Grants from the National Institutes of Health
- • Limited Competition for NIH-Industry Program: Discovering Pediatric New Therapeutic Uses f...
- • Environmental influences on Placental Origins of Development (ePOD) (R01)
- • Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
- • Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existin...
- • Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01)